Study Stopped
NIH terminated the study due to shifted policy priorities
Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men
Still Climbin': A Randomized Controlled Trial to Improve Coping, Medical Mistrust, and Healthcare Engagement Among Black Sexual Minority Men
1 other identifier
interventional
369
1 country
1
Brief Summary
This study consists of a randomized controlled trial of a multi-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Primary intervention objectives include increasing health care engagement and receipt of evidence-based preventive care, as well as better coping and reduced anticipated and internalized stigma, and medical mistrust among intervention participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedStudy Start
First participant enrolled
February 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2025
CompletedResults Posted
Study results publicly available
November 13, 2025
CompletedNovember 13, 2025
October 1, 2025
4.1 years
October 1, 2020
October 7, 2025
October 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Inadequate Healthcare Utilization
Indicator that the individual reported (1) fewer than 1 ambulatory visit AND (2) at least 1 emergency department visit (without subsequent hospitalization) or at least 1 hospitalization in the past 4 months at any of the 3 follow-up assessments (4, 8, and 12 months post-baseline)
baseline to 12-month post-baseline
Proportion of Evidence-based Care Components Received Across Follow-up Assessments
For each individual, this measure is the number of components that were received at any time across the 3 follow-up assessments divided by the number of components they were eligible for at any time across the 3 follow-up assessments, expressed as a proportion. 25 components were evaluated and eligibility for each component varies by individual and follow-up period.
baseline to 12 months post-baseline
Secondary Outcomes (1)
Adaptive Coping Strategies (Social Support Seeking)
4-, 8-, and 12-months post-baseline
Study Arms (2)
Intervention
EXPERIMENTALThe intervention is an 8-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM).
No-treatment control
NO INTERVENTIONParticipants who are assigned to the control group will not receive the intervention.
Interventions
A cognitive behavior therapy group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM).
Eligibility Criteria
You may qualify if:
- years of age or older
- Biologically male at birth
- Identify as male
- Self-identify as a Black/African American
- Report having sex with men in the past 24 months
- Anticipate being available for the next 12 months to attend study visits
- Able to interact and communicate in written and spoken English.
You may not qualify if:
- Unwilling/Unable to provide informed consent
- Cisgender women
- Transgender women
- Transgender men
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RANDlead
- University of Massachusetts, Bostoncollaborator
- University of Southern Californiacollaborator
- APLA Healthcollaborator
Study Sites (1)
APLA Health
Los Angeles, California, 90016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura Bogart
- Organization
- RAND
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Bogart, PhD
RAND
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessor does not randomize participant until after the baseline assessment
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2020
First Posted
October 14, 2020
Study Start
February 9, 2021
Primary Completion
March 20, 2025
Study Completion
March 20, 2025
Last Updated
November 13, 2025
Results First Posted
November 13, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- For three years, following publication of the main study papers.
- Access Criteria
- Users must agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data resource. Users must notify the institutional review board of their institution of their intention to use the data and their procedures for data management and security. Users must submit proposals regarding intended use of the data; the RAND study team and the RAND Human Subjects Protections Committee (HSPC) will determine the scientific soundness of the proposal as part of the decision for the researcher to be able to access the dataset.
Following publication of the main study papers, de-identified survey data will be made publicly available to researchers who successfully complete a registration process after requesting to use the data. The data made available will not contain any direct or indirect identifiers. Users must agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data resource.